KIYATEC Announces Enrollment of First Patients in Clinical Trial to Predict Personalized Response to Oncology Drugs …

The 3D-PREDICT Study is a prospective, open-label, multi-institutional, non-interventional study to validate the EV3D assay for clinical use and to investigate the impact on outcomes for cancer patients with both newly diagnosed and recurrent epithelial ovarian cancer and recurrent high-grade gliomas, which include glioblastomas (GBM). Over the next year or so, the study will expand […]

LabConnect and Symphony Clinical Research Partner to Improve In-Home Clinical Services

LabConnect and Symphony Clinical Research Partner to Improve In-Home Clinical Services

SEATTLE–(BUSINESS WIRE)–Jun 20, 2018–LabConnect, LLC, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, and Symphony Clinical Research, a worldwide, innovative in-home clinical service provider, today announced a strategic collaboration. The two companies have worked together on 17 studies over 12 years and will now focus […]

Biotech Resurgent Growth Championed by Cancer Research and Clinical Trial Advancements

Biotech Resurgent Growth Championed by Cancer Research and Clinical Trial Advancements

The biotech industry has been headlined by a growing number mergers and acquisitions, but focus of late surrounds optimistic developments regarding cancer research and developments as well as advanced therapeutic treatments. Biotech and Pharma firms in the markets have recently released progress on a number of treatments, including clinical trial updates for the advancement of […]

Clinical trial firm Greenphire partners with Lyft to give rides for patients testing experimental care

Clinical trial firm Greenphire partners with Lyft to give rides for patients testing experimental care

A King-of-Prussia-based company is making access to clinical trials easier for patients by giving them a Lyft. Greenphire, a 150-person, financial software provider for clinical trials, is partnering with ride-share company Lyft to help clinical trial sites book rides for participants and reimburse them for any transportation costs. “Greenphire’s mission is to remove the barriers of […]

CytoDyn Provides Update on Phase 2 Clinical Trial with PRO 140 in GvHD

CytoDyn Provides Update on Phase 2 Clinical Trial with PRO 140 in GvHD

Patient enrollment proceeding under amended protocol VANCOUVER, Washington, June 20, 2018 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company developing new antibody therapies for combating human immunodeficiency virus (HIV) infection and immunologic indications, announces that an amended protocol for the Phase 2 trial with PRO 140 in patients with graft-versus-host disease (GvHD) has received […]

Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA …

Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA …

DUBLIN, Ireland, June 19, 2018 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience category, today announced that results from the Phase 1b multiple ascending dose study of PRX002/RG7935, an investigational monoclonal antibody for the potential treatment of Parkinson’s disease, has […]

ITM: FDA Acceptance of IND to Advance Phase III Clinical Trial COMPETE with Solucin

ITM: FDA Acceptance of IND to Advance Phase III Clinical Trial COMPETE with Solucin

GARCHING, Germany–(BUSINESS WIRE)–Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug Application (IND) to advance its innovative radiopharmaceutical Solucin® (n.c.a. 177Lu-Edotreotide), into a phase III clinical trial in the U.S.. The COMPETE trial is led as an international, […]

Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis

Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis

BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (HA) technology platform, today announced results from its CINGAL® 16-02 clinical trial, an active-comparator Phase III study being conducted to support U.S. registration. CINGAL has previously been evaluated in a placebo-controlled […]

Greenphire Partners with Lyft to Support Clinical Trial Patient Retention and Access

Greenphire Partners with Lyft to Support Clinical Trial Patient Retention and Access

“Expense management and ground transportation are critical to participant retention. However, patient and site needs are not equal. That is why we have designed the only application that allows a study coordinator to order a car, reimburse for a ride, and provide a stipend all within one software,” said Jim Murphy, CEO, Greenphire. Greenphire’s ClinCard […]